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Highlights1
All outpatient antibiotics prescriptions for Qatari national were reviewed2
Nearly 45% of prescribed antibiotics were deemed inappropriate based on the associated diagnosis3
Highest proportion of inappropriate use was for upper respiratory infections4
5
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Abstract50
Background: Antibiotic are often inappropriately prescribed for upper respiratory infections (URI) in the 51
Western countries. Data on the proportion of inappropriate prescriptions are lacking from the Middle 52
East and other developing countries.53
Methods: We retrieved health insurance claims for all antibiotics prescribed for URIs in the private54
sector in the State of Qatar between May 2014 and December 2015. During the study period, health 55
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insurance was limited to Qatari nationals. We excluded topical antibiotics. We also retrieved data on 56
prescriber’s specialty as listed with the licensing authority. Diagnoses were classified as appropriate or 57
inappropriate based on the likelihood of a bacterial etiology which may warrant antibiotic use. 58
Results: There were a total of 75,733 claims during the study period. Of these, 41,556 (55%) were for an 59
appropriate indication, while 34,177 (45%) were for an inappropriate indication. Most common 60
antibiotic classes were cepahlosporins (43% of claims; 44% inappropriate), penicillins (28% of claims; 61
44% inappropriate), macrolides (19% of claims; 52% inappropriate) and fluoroquinolone (9% of claims; 62
40% inappropriate). Nearly 5% of antibiotics were intravenous formulations. The most common 63
prescribers were General/Family physicians (53% of claims; 50% inappropriate), followed by Pediatrics 64
(18.6% of claims; 36% inappropriate) and Internal Medicine (14.1 of claims; 44% inappropriate). 65
Conclusions: There is a high rate of inappropriate antibiotic prescription for acute URIs in the private 66
health care sector in the State of Qatar. Further studies are needed to determine the population based 67
rates across the country. Interventions to decrease inappropriate use in such settings are urgently 68
needed.69
70
Key words: Antibiotics; inappropriate; upper respiratory tract;71
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Inappropriate antibiotic use is associated with increasing antibiotic resistance, healthcare costs, adverse 73
events and poorer outcomes. The global magnitude of inappropriate antibiotics prescription is not well 74
defined. In a recent study from the US, nearly one-third of the antibiotics prescribed in the outpatient 75
setting were deemed to be inappropriate.1 Upper respiratory tract infections are the most frequent 76
diagnoses associated with antibiotics prescription in the outpatient setting, accounting for nearly half of 77
such prescriptions.2 Between 30-64% of the antibiotics prescribed for upper respiratory tract infections 78
are considered to be inappropriate.1,3-6 There are variations in the rates of inappropriate antibiotics 79
prescriptions, with much lower rates reported from some European countries compared to the US.780
Factors associated with inappropriate antibiotic prescription include care setting (private vs. public 81
hospitals),2 patient characteristics (age, female gender, non-White race/ethnicity, education status, 82
smoking),3,5,8 socioeconomic factors (insurance status),3 and provider factors (provider specialty).383
Higher rates of inappropriate prescription have been linked with higher antimicrobial resistance rates.984
85
The rates and patterns of antibiotic use in the outpatient setting in the Middle Eastern and Gulf 86
Cooperation Council (GCC) countries are unknown. Previous studies have shown high levels of 87
antimicrobial resistance in the GCC countries, but the link to antibiotic prescription patterns has not 88
been established. Qatar is a member of the six nation GCC (others being Kingdom of Saudi Arabia, 89
United Arab Emirates, Bahrain, Kuwait and Sultanate of Oman). Qatar introduced a health insurance 90
scheme for Qatari nationals in 2014 under which all claims were submitted to the National Health 91
Insurance Company for payment. The health insurance scheme was planned to be eventually scaled up 92
to the entire population of Qatar, both Qatari nationals and the expatriate population. We conducted 93
this study to determine the rate of inappropriate antibiotic prescription in the outpatient private sector 94
for upper respiratory tract infections.95
96
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Methods97
We retrieved deidentified health insurance claims information for upper respiratory tract infections 98
submitted to the National Health Insurance Company (NHIC) for reimbursement between May 2014 and 99
December 2015. The NHIC receives claims from clinical providers across Qatar for Qatari nationals. 100
Diagnoses are based on International Classification for Diseases, 10th edition, Australian modification 101
(ICD10-AM). We selected claims associated with common upper respiratory infections diagnoses, using a 102
modified list adapted from Fleming-Dutra et al, for common respiratory conditions.1 We divided the 103
diagnoses into two categories; 1) those for which antibiotics are generally indicated (appropriate 104
prescriptions), and 2) those for which antibiotics are generally not indicated (inappropriate 105
prescriptions). The former included diagnoses most likely to have a bacterial etiology and the latter 106
included those diagnoses most likely to have a viral etiology. Since there are no national guidelines for 107
use of antibiotics in such settings in Qatar, we used expert opinion of infectious diseases specialists to 108
categorize diagnoses into appropriate and inappropriate based on best published evidence. It is quite 109
possible that there may be an overlap in some categories, and other categories may have varied 110
etiology. In conditions where bacterial and viral etiologies were equally likely, or a preponderance of 111
evidence did not clearly identify the etiology to be viral, we erred on the side of conservatism in labelling 112
antibiotic use as appropriate for such conditions. We then retrieved all antibiotic prescriptions 113
submitted with those claims. Claims for medications prescribed are submitted along with primary 114
diagnoses associated with the claim. We excluded claims for topical antibiotics. The claims were 115
restricted to providers in the private sector and to Qatari nationals due to the gradual phasing-in 116
approach of the national health insurance plan.117
118
We tabulated antibiotics prescription by condition and by age category. We also tabulated prescription 119
by specialty/subspecialty of the prescriber as recorded with the regulatory authorities in Qatar 120
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(Supreme Council of Health at the time of study), and calculated the proportion of claims that were 121
rejected by specialty/subspecialty. We also tabulated number of claims by individual antibiotic and 122
antibiotic class and the proportion of claims rejected for each antibiotic and antibiotic class. Finally, we 123
plotted antibiotics claims per month for the study period to demonstrate the seasonal variation in 124
antibiotic prescription.125
126
Since all data retrieved were deidentified and there was no contact with the participants, we sought a 127
waiver of informed consent from the Institutional Review Board at Hamad Medical Corporation, which 128
approved the study.129
130
131
Results132
Between May 2014 and December 2015, there were 75,733 claims for non-topical antibiotics that were 133
prescribed for acute upper respiratory tract infections. (Table 1) The breakdown of claims by diagnosis 134
and age categories is provided in table 1. Overall, 45% of the antibiotics were deemed inappropriate 135
based on the accompanying diagnosis. There was a trend towards increasing inappropriate use with 136
increasing age groups (42% for age group 0-17 years; 47% for 18-65 years; 54% for >65 years). The 137
diagnoses most commonly associated with inappropriate antibiotic prescription were acute upper 138
respiratory tract infections, including viral upper respiratory infections (28,898 claims; 85% of 139
inappropriate prescription). The largest number of prescriptions were by General/Family Practice 140
physicians, accounting for 52.7% of the prescriptions (50% inappropriate), followed by Pediatrics (18.6% 141
of prescriptions; 36% inappropriate) and Internal Medicine (14.1 of prescriptions; 44% inappropriate). 142
Emergency Medicine physicians accounted for only 2% of the prescriptions, but the highest number of 143
inappropriate prescriptions (74%) among those with >1,000 claims. (Table 2)144
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145
Cephalosporins were the most commonly prescribed group of antibiotics (43% of all claims), followed by 146
penicillins (including combination with enzyme inhibitors, e.g. amoxicillin-clavulanate, 28%), macrolides 147
(19%) and fluoroquinolones (9%). (Table 3) Nearly 5% of all claims were for intravenous antibiotics. 148
(Table 4) Although data are not available for two complete years, there were less claims for antibiotics 149
in the peak summer months (June-September) compared with rest of the year. (Figure 1)150
151
A detailed list of all antibiotics prescribed and proportion of inappropriate prescriptions for each 152
antibiotic are presented in supplementary table 1. A detailed list of each antibiotic class and associated 153
diagnoses for which they were prescribed are presented in supplementary table 2.154
155
156
Discussion:157
In this study of outpatient Qatari population in the private sector, we found that 45% of the patients 158
who were prescribed antibiotics for upper respiratory tract infections were for an inappropriate 159
indication. The largest number of prescriptions were from General/Family Practice physicians, followed 160
by Pediatrics, Internal Medicine, Otolaryngology and Emergency Medicine physicians. Together, these 161
five specialties accounted for nearly 99% of all prescriptions for upper respiratory infections. 162
Inappropriate prescription rate was lowest among the Pediatrics physicians (34%) and highest among 163
the Emergency Department physicians (74%) among this group.164
165
There is an increasing recognition and concern about inappropriate antibiotics prescriptions globally. 166
Despite concerns of increasing antibiotic resistance, increasing costs and potential adverse events, there 167
is no clear indication that inappropriate antibiotic prescription rates are decreasing. After an initial 168
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decline in the 1990s and 2000s, the overall prescription rates have stabilized or reversed.10 There are 169
significant differences in such prescriptions in various countries, and higher rates of inappropriate 170
prescriptions are associated with higher rates of antimicrobial resistance.9,11,12 Upper respiratory tract 171
infections are by far the most common diagnosis for which antibiotics are prescribed in outpatient 172
settings, accounting for nearly 80% of all such prescriptions.13,14 Adherence to guidelines for antibiotic 173
prescriptions in outpatient setting is low in the absence of active interventions.4 It has been shown that 174
behavioral interventions and peer comparison reports can lead to a decrease in inappropriate antibiotic 175
prescriptions, even in absence of restricting prescriptions or changing how physicians are paid.11 A 176
review of literature also suggested that educational interventions were associated with a decrease in 177
inappropriate prescription in two-thirds of the studies reviewed.15 Institution of such intervention 178
programs may be beneficial in the State of Qatar to reduce inappropriate antibiotic use.179
180
We found that the Emergency Department physicians were more likely to prescribe antibiotics for an 181
inappropriate indication compared with other specialties. This may be due to the acute nature of the 182
presenting illness perceived to be severe enough to warrant an emergency department visit, lack of 183
proper follow up after discharge from the emergency departments, physician related factors or other 184
unknown causes. Such data may help inform policy makers who to target first in education and 185
behavioral intervention campaigns.186
187
An interesting finding was the use of intravenous antibiotics in nearly 5% of the outpatients in our study. 188
There is rarely a justification for use of intravenous antibiotics in the outpatient setting. While the 189
inappropriate use among the intravenous prescriptions was only 23% (about half that for oral 190
antibiotics), the reasons for this are unclear. A diagnosis appropriate for antibiotic prescription may have 191
led the prescribers to believe that the illness is more severe, or a perception that intravenous antibiotics 192
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are more potent, efficacious or effective. Whether patient preferences played a part in such 193
prescriptions is unknown.194
195
Another interesting finding is the lower number of prescriptions during the summer months. In general, 196
the incidence of upper respiratory tract infections is higher in the winter months. However, the 197
population movement patterns in the GCC states are such that a large segment of the migrant workers 198
return to their home countries for the summer break, and the Qatari nationals travel abroad for leisure. 199
A smaller Qatari population would lead to a smaller denominator or persons seeking treatment, and a 200
smaller overall population may be associated with lower transmission rates. Whether the lower 201
numbers in Qatar during the summer months are due to the natural epidemiologic patterns seen around 202
the world, or due to a much smaller population base in those months warrants further study.203
204
A strength of our study is the use of national outpatient data in the private sector. We also retrieved 205
information on the specialty of the prescribers. Limitations of our study include exclusion of non-Qatari 206
nationals from the first phase of health insurance scheme, limitation to the private sector providers, and 207
our inability to generate rates of prescription per unit population (e.g. per 1,000 persons) due to lack of 208
information on how many persons exclusively seek private sector vs. public sector care. Exclusion of 209
these groups could lead to under- or over-estimation of inappropriate use. We also did not study the 210
antibiotic prescription rates for conditions other than upper respiratory tract infections. Another 211
limitation is the possibility of misclassification of infection by the practitioner. Finally, the etiology of 212
some of the conditions is not always clear and a small but significant proportion of those with 213
predominantly viral syndromes may have a bacterial etiology and vice versa.214
215
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In conclusion, there is a high rate of inappropriate antibiotic prescription for acute upper respiratory 216
tract infections in the private health care sector in the State of Qatar. Further studies are needed to 217
determine the population based rates across the country. Interventions to decrease inappropriate use in 218
such settings are urgently needed.219
220
221
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Table 1. Total number of claims by diagnosis and age group.222
Diagnosis All Ages 0 – 17 years 18 – 65 years >65 years
N % N % N % N %
Antibiotics may be indicated (Appropriate Prescriptions)
Acute pharyngitis including 
streptococcal pharyngitis
23,232 56% 10,119 58% 12,826 54% 287 69%
Acute sinusitis including acute 
maxillary sinusitis
5,908 14% 880 5% 4,957 21% 71 17%
Acute tonsillitis including 
Streptococcal tonsillitis
12,399 30% 6,382 37% 5,961 25% 56 14%
Influenza with pneumonia 17 0% 15 0% 2 0% 0 0%
TOTAL 41,556 17,396 23,746 414
Antibiotics not indicated (Inappropriate Prescriptions)
Acute laryngitis 442 1% 153 1% 284 1% 5 1%
Acute nasopharyngitis including 
common cold
4,647 14% 2,454 19% 2,155 10% 38 8%
Acute upper respiratory tract 
infections, including viral URI
28,898 85% 10,088 79% 18,375 88% 435 91%
Influenza 109 0% 33 0% 75 0% 1 0%
Pain in throat 81 0% 27 0% 54 0% 0 0%
TOTAL 34,177 12,755 20,943 479
Total number of claims 75,733 -- 30,151 -- 44,689 -- 893 --
Inappropriate prescriptions, % -- 45% -- 42% -- 47% -- 54%
223
224
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224
Table 2. Total number and proportion of inappropriate claims by specialty of the prescriber.225
Specialty Total Claims, N Inappropriate Prescriptions, %
General/Family Practice 39,889 50%
Paediatrics 14,066 36%
Internal Medicine 10,658 44%
ENT/Otology 8,691 35%
Emergency Medicine 1,472 74%
Public Health 276 54%
General Surgery 189 32%
Pulmonary Diseases 130 64%
Gastroenterology 91 40%
Nephrology 78 97%
Endocrinology & Metabolism 58 19%
Obstetrics & Gynaecology 44 73%
Infectious Diseases 29 24%
General Scope Nurse 27 37%
Others 35 63%
Grand Total 75,733 45%
226
227
228
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228
Table 3. Cost and proportion of inappropriate us by antibiotic class.229
Antibiotic Class Total Claims, N Inappropriate Prescriptions, %
Cephalosporin 32,811 44%
Penicillin including combination 
with enzyme inhibitor
20,912 44%
Macrolides 14,681 52%
Fluoroquinolones 6,498 40%
Others 831 44%
Grand Total 75,733 45%
230
231
Table 4. Cost and proportion of inappropriate us by route of administration.232
Route of Administration Total Claims, N Inappropriate Prescriptions, %
PO 72,024 46%
IV 3,627 23%
Undetermined 82 46%
Grand Total 75,733 45%
233
234
235
236
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236
Figure 1. Seasonal variation in prescription of antibiotics to Qatari patients for upper respiratory tract 237
infections.238
239
240
241
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